Get started
Author

Michael R. Hodges

Observed names: M Hodges, M R Hodges, M. HODGES, M. Hodges, M. R. HODGES, M. R. Hodges, M.R. HODGES, M.R. Hodges, M. R. Hodges, MICHAEL HODGES, MICHAEL R. HODGES, Michael Hodges, Michael R Hodges, Michael R. Hodges
Observed institutions: National Institutes of Health, Institut Pasteur, Duke University, Pfizer (United States), Pfizer (United Kingdom), University of Utah, University of South Florida, Wilford Hall Ambulatory Surgical Center, University of Florida Health, University of Florida, United States Air Force, Amplyx Pharmaceuticals (United States), Ohio State University Hospital, Alexion Pharmaceuticals (United States), Duke Medical Center, National Cancer Institute, AtlantiCare, Roche (Denmark), Bacterial RNAs & Medicine, Duke Clinical Research Institute, The Ohio State University, University of Florida Health Science Center
ORCID: 0009-0003-3052-2344
Observed ORCID: 0009-0003-3052-2344
OpenAlex ID: A5025876809
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
2002 · Raoul Herbrecht, David W. Denning, et al. · New England Journal of Medicine · 3,304
PDF
Treatment of HCV Infection by Targeting MicroRNA
2013 · Harry L.A. Janssen, Hendrik W. Reesink, et al. · New England Journal of Medicine · 2,209
PDF
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
2002 · THOMAS J. WALSH, IRJA LUTSAR, et al. · The Pediatric Infectious Disease Journal · 431
A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
2001 · R. Ally, D. Schürmann, et al. · Clinical Infectious Diseases · 332
PDF
In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
2014 · Søren Ottosen, Todd B. Parsley, et al. · Antimicrobial Agents and Chemotherapy · 231
Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients
2014 · Meike H. van der Ree, Adriaan J. van der Meer, et al. · Antiviral Research · 199
Ventilatory Pattern, Interpleural Pressure, and Cardiac Output
1977 · JOHN B. DOWNS, MICHAL E. DOUGLAS, et al. · Anesthesia & Analgesia · 107
Sildenafil citrate (viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects
1999 · Wallace W Dinsmore, Michael Hodges, et al. · Urology · 102
Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial
2015 · Eveline P. van Poelgeest, Michael R. Hodges, et al. · British Journal of Clinical Pharmacology · 95
PDF
Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial
2023 · Jose A. Vazquez, Peter G. Pappas, et al. · Antimicrobial Agents and Chemotherapy · 92
Acute Kidney Injury During Therapy With an Antisense Oligonucleotide Directed Against PCSK9
2013 · Eveline P. van Poelgeest, Reinout M. Swart, et al. · American Journal of Kidney Diseases · 90
Inducing Hepatitis C Virus Resistance After Pig Liver Transplantation—A Proof of Concept of Liver Graft Modification Using Warm Ex Vivo Perfusion
2016 · N. Goldaracena, V.N. Spetzler, et al. · American Journal of Transplantation · 85
Lithium Carbonate and Neuromuscular Blocking Agents
1977 · Gary E. Hill, K. C. Wong, et al. · Anesthesiology · 83
Change in Pulmonary Venous Admixture With Varying Inspired Oxygen
1976 · MICHAEL E. DOUGLAS, JOHN B. DOWNS, et al. · Anesthesia & Analgesia · 72
Comparison of Venous Air Embolism Monitoring Methods in Supine Dogs
1978 · John B. English, Dwayne Westenskow, et al. · Anesthesiology · 70
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial
2023 · Peter G Pappas, Jose A Vazquez, et al. · Journal of Antimicrobial Chemotherapy · 65
PDF
HCV Infection and Miravirsen
2013 · Harry L A Janssen, Sakari Kauppinen, et al. · New England Journal of Medicine · 64
58 Final Results – Randomized, Double-blind, Placebo-controlled Safety, Anti-viral Proof-of-concept Study of Miravirsen, an Oligonucleotide Targeting Mir-122, in Treatment-naive Patients With Genotype 1 Chronic Hcv Infection
2012 · H.W. Reesink, H.L.A. Janssen, et al. · Journal of Hepatology · 60
Tracheal Pathology Following Short-Term Intubation with Low-and High-Pressure Endotracheal Tube Cuffs
1978 · EDWARD A. LOESER, MICHAEL HODGES, et al. · Anesthesia & Analgesia · 57
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers
2023 · Michael R. Hodges, Eric Ople, et al. · Antimicrobial Agents and Chemotherapy · 52
Cardiovascular Responses to Nitrous Oxide During Light, Moderate, and Deep Halothane Anesthesia in Man
1978 · GARY E. HILL, JOHN E. ENGLISH, et al. · Anesthesia & Analgesia · 51
Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1
2018 · Joshua F. Apgar, Jian‐Ping Tang, et al. · CPT Pharmacometrics & Systems Pharmacology · 47
PDF
Phase 1 Study to Assess Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of APX001 and to Investigate the Effect of Food on APX001 Bioavailability
2017 · Michael R Hodges, Eric Ople, et al. · Open Forum Infectious Diseases · 45
PDF
Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS)
2025 · Michael R Hodges, Margaret Tawadrous, et al. · Clinical Infectious Diseases · 43
Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Candida Endophthalmitis and Hematogenous Meningoencephalitis in Nonneutropenic Rabbits
2020 · Ruta Petraitiene, Vidmantas Petraitis, et al. · Antimicrobial Agents and Chemotherapy · 43
Works count: 74
Citation count: 8,469
H-index: 28
I10-index: 46
Year
Topic
Type